Repligen | RGEN - 股本和储备

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 7.89B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	股本和储备	更改		日
Agilent	USD 7.12B		214M	2026-03
Align Technology	USD 4.15B		100.27M	2026-03
Bio Techne	USD 2.09B		74.32M	2026-03
BioMarin Pharmaceutical	USD 6.21B		125.11M	2026-03
Bristol-Myers Squibb	USD 20.07B		1.6B	2026-03
Bruker	USD 2.46B		35.9M	2025-12
Charles River Laboratories	USD 2.9B		265.94M	2026-03
Danaher	USD 52.95B		415M	2026-03
Dentsply International	USD 1.32B		21M	2026-03
General Electric Aerospace	USD 18.06B		841M	2026-03
Henry Schein	USD 3.27B		21M	2026-03
Illumina	USD 2.68B		47M	2026-03
IQVIA Holdings	USD 6.22B		282M	2026-03
Mettler Toledo International	USD -41.88M		18.25M	2026-03
Myriad Genetics	USD 337.4M		30.6M	2026-03
OraSure Technologies	USD 313.32M		27.5M	2026-03
Pacific Biosciences Of California	USD 2.37M		2.98M	2026-03
Pfizer	USD 90.1B		3.63B	2026-03
Repligen	USD 2.11B		666K	2026-03
Revvity	USD 7.25B		125.54M	2025-12
Standard Biotools	USD 561.12M		136.83M	2026-03
Thermo Fisher Scientific	USD 51.93B		1.6B	2026-03
Waters	USD 2.56B		230.55M	2025-12
West Pharmaceutical Services	USD 2.99B		185.6M	2026-03